000448 UTILIZABILITY OF THE SERUM IGF-1, IGFBP-3, LEPTIN AND CA-125 LEVELS IN BENIGN-MALIGN DIFFERENTIATION IN PATIENTS WITH OVARIAN TUMORS. (1st September 2005)